The U.S. Health Resources and Services Administration said late Friday that when the COVID-19 public health emergency ends on Thursday, so too will a nearly three-year-old policy clarification that lets hospitals under certain conditions dispense 340B drugs at offsite outpatient clinics not yet registered in the 340B program because they are not yet listed on the hospital’s most recently filed Medicare cost report.
HRSA told 340B Report in early June 2020 two days after it announced that policy clarification that it was “in place regardless of the COVID-19 pandemic.” 340B hospital representatives said at the time the decision was significant and long overdue. HRSA’s about-face probably will shock many of them.
The U.S. Health Resources and Services Administration said late Friday that when the COVID-19 public health emergency ends on Thursday, so too will a nearly three-year-old policy clarification that lets hospitals under certain conditions dispense 340B drugs at offsite outpatient […]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
